Business
Marinomed Biotech : Form for proxy to IVA (2026 Vollmacht IVA EN FINAL)
Marinomed Biotech : Form for proxy to IVA (2026 Vollmacht IVA EN
About this update from Marinomed Biotech Ag
[{"type":"text","content":"\n PROXY\n \n \n \n As shareholder(s) of Marinomed Biotech AG, I/we hereby authorize\n \n \n \n Mr. Florian PRISCHL\n \n \n \n c/o IVA - Interessenverband für Anleger, Feldmühlgasse 22, 1130 Vienna, Austria\n to represent me/us at the 9th Annual General Meeting of Marinomed Biotech AG, FN 276819 m, to be held on Thursday, June 11, 2026, at 13:00 (Vienna time), as shareholder(s) and to exercise all rights to which I am/we are entitled as shareholder(s) of Marinomed Biotech AG, including, but not limited to the voting right.\n In particular, I/we authorize the above-mentioned proxy holder to vote on my/our behalf and pass resolutions regarding the following agenda items:\n \n \n Resolution on the discharge of the members of the Management Board for the 2025 financial year\n \n \n Resolution on the discharge of the members of the Supervisory Board for the 2025 financial year\n \n \n Election of the auditor for the 2026 financial year\n \n \n Resolution on the remuneration report 2025\n \n \n Resolution on (a) the revocation of the resolution of the General Assembly dated 11 June 2025 on the reduction of the number of members of the Supervisory Board due to resignation and (b) election of one person into the Supervisory Board\n \n \n Resolution on (a) the revocation of the authorization of the management issued under item 7 of the agenda of the General Assembly dated 20 June 2024 to issue financial instruments pursuant to section 174 Austrian Stock Corporation Act (AktG) as far as such authorization has not yet been utilized and simultaneously (b) the authorization of the Board of Directors to issue financial instruments pursuant to section 174 Austrian Stock Corporation Act (AktG), in particular convertible bonds, profit participating bonds, participation rights providing acquisition of and/or conversion and change into shares of the company including partial exclusion of subscription rights (direct exclusion) and authorization to exclude subscription rights of shareholders upon approval of the Supervisory Board;\n \n \n Resolution on (a) the revocation of the contingent capital 2024 as far as not yet utilized and simultaneously (b) the contingent increase of the share capital of the company pursuant to section 159 para 2 lit 1 Austrian Stock Corporation Act (AktG) in order to (i) honour and issue to holders of financial instrument...